FE ATURES
NEW YORK SPINE INSTITUTE BRINGS
WORLD-CLASS SPINE CARE
TO LONG ISLAND 06
Since its inception 16 years ago, the New York Spine Institute
has grown into a tri-state leader in neck and back care.
DRUG ALTERS APPROACH TO TREATING
ADVANCED MELANOMA 24
Restoring the body 's ability to detect and attack cancer is
the focus of a newer class of drugs that is transforming how
physicians fight advanced melanoma. Pembrolizumab is
leading the charge.
DEPARTMENTS
FINANCE 11
LEGAL EASE 12
PRODUCT SPOTLIGHT 14
PEOPLE IN THE NEWS 16
CME CREDITS 26
LOCAL NEWS 29
06
contents
ON THE COVER
/////// JUNE 2016
SPECIAL CLINICAL SECTION:
NEUROLOGY
A WAY FORWARD IN TREATING
PRIMARY-PROGRESSIVE
MULTIPLE SCLEROSIS? 20
Roughly 15 percent of people with multiple sclerosis have
the primary-progressive form of the disease, and e-ective
treatments for these patients have been scarce. Results from a
phase 3 study of the drug ocrelizumab may change that.
STROKE TREATMENT USES BLOOD FLOW TO
TRIGGER tPA RELEASE 22
A novel use of a stent and nanoparticles coated with tissue
plasminogen activator holds promise for rapidly dissolving
blood clots while minimizing vascular injury.
NEUROLOGY UPDATE 23
A roundup of news related to neurolog y
11
24
